Psephos Biomedica enabled Artiria Medical to achieve FDA 510(k) clearance for its SmartGUIDEā¢ device, accelerating its path to market.
Psephos Biomedica assisted Invicta Medical to navigate the necessary regulatory pathways and accelerate clinical development of its medical technology.
Psephos Biomedica supported Attomarker in achieving MHRA emergency use exemption and CE marking for its Liscar6 COVID-19 antibody testing device.
This case study features the Surrey and Borders Partnership NHS Foundation Trust TIHM project which Psephos was involved in throughout 2020.
